The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?
Recruiting
N/A
Interventional Study
Myopia
Refractive Ametropia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 40
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 224 (estimated)
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the effect of intraoperative kappa-angle compensation on postoperative visual quality in patients undergoing small incision lenticule extraction (SMILE) using the VisuMax 800 platform. The study will enroll patients with myopia and a kappa-angle offset \< 0.2 mm.
The main questions it aims to answer are:
Does intraoperative kappa-angle compensation …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients aged 18 to 40 years with myopia or myopic astigmatism and stable refraction for \>=1 year, whose refractive errors fall within the treatable range of and meet the indications for SMILE surgery.
2. Normal corneal morphology and corneal thickness meeting surgical requi…
Contacts
No contact information available.